Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PMX-205 is a cyclic hexapeptide that acts as a potent antagonist of C5a receptor (C5aR; IC50 = 31 nM).1 It is orally active and blocks inflammatory signaling and symptoms in animal models of colitis and allergic asthma.2,3 PMX-205 is also brain penetrant and reduces neuroinflammation and neurodegeneration in an animal model of Alzheimer’s disease.4
WARNING This product is not for human or veterinary use.
1. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity. Mol. Pharmacol. 65(4), 868-879 (2004).
2. The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-
3. Treatment with the C5a receptor/CD88 antagonist PMX205 reduces inflammation in a murine model of allergic asthma. Int. Immunopharmacol. 21(2), 293-300 (2014).
4. Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer’s disease. J. Immunol. 183(2), 1375-1383 (2009).